Axi-cel Retreatment in Relapsed/Refractory LBCL

Clinical trial NCT05800067 · UNKNOWN

Trial details

NCT number: NCT05800067
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

CAR-T Retreatment

Start date: 2023-03-04
Primary completion: 2024-12-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.